Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$209.01 - $232.56 $14,630 - $16,279
-70 Reduced 2.64%
2,582 $564,000
Q4 2023

Jan 31, 2024

BUY
$197.69 - $227.29 $18,385 - $21,137
93 Added 3.63%
2,652 $602,000
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $12,465 - $13,745
62 Added 2.48%
2,559 $514,000
Q2 2023

Aug 09, 2023

BUY
$211.93 - $241.33 $171,663 - $195,477
810 Added 48.01%
2,497 $602,000
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $32,424 - $39,190
152 Added 9.9%
1,687 $387,000
Q4 2022

Jan 25, 2023

SELL
$203.72 - $248.97 $44,614 - $54,524
-219 Reduced 12.49%
1,535 $361,000
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $13,722 - $17,566
-67 Reduced 3.68%
1,754 $359,000
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $7,057 - $9,169
-33 Reduced 1.78%
1,821 $427,000
Q1 2022

Apr 27, 2022

SELL
$259.82 - $298.18 $168,103 - $192,922
-647 Reduced 25.87%
1,854 $489,000
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $539,940 - $624,649
-1,988 Reduced 44.29%
2,501 $786,000
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $7,694 - $8,633
28 Added 0.63%
4,489 $1.26 Million
Q2 2021

Aug 10, 2021

SELL
$251.87 - $278.14 $324,156 - $357,966
-1,287 Reduced 22.39%
4,461 $1.23 Million
Q1 2021

Apr 30, 2021

SELL
$204.88 - $255.03 $5.9 Million - $7.34 Million
-28,777 Reduced 83.35%
5,748 $1.47 Million
Q4 2020

Feb 08, 2021

BUY
$186.91 - $214.42 $632,503 - $725,597
3,384 Added 10.87%
34,525 $7.03 Million
Q3 2020

Oct 30, 2020

BUY
$167.03 - $201.3 $68,315 - $82,331
409 Added 1.33%
31,141 $5.86 Million
Q2 2020

Aug 12, 2020

BUY
$113.31 - $182.44 $546,380 - $879,725
4,822 Added 18.61%
30,732 $5.11 Million
Q1 2020

Apr 29, 2020

BUY
$104.32 - $195.28 $214,377 - $401,300
2,055 Added 8.61%
25,910 $3.28 Million
Q4 2019

Feb 11, 2020

BUY
$163.48 - $173.61 $86,971 - $92,360
532 Added 2.28%
23,855 $4.04 Million
Q3 2019

Nov 08, 2019

BUY
$159.77 - $178.1 $136,603 - $152,275
855 Added 3.81%
23,323 $3.92 Million
Q2 2019

Jul 24, 2019

BUY
$144.16 - $172.9 $58,673 - $70,370
407 Added 1.84%
22,468 $3.89 Million
Q1 2019

May 08, 2019

SELL
$123.7 - $156.3 $14,596 - $18,443
-118 Reduced 0.53%
22,061 $3.38 Million
Q4 2018

Feb 07, 2019

SELL
$120.82 - $174.09 $357,627 - $515,306
-2,960 Reduced 11.77%
22,179 $2.8 Million
Q3 2018

Oct 29, 2018

BUY
$167.67 - $188.27 $190,137 - $213,498
1,134 Added 4.72%
25,139 $4.37 Million
Q2 2018

Aug 07, 2018

BUY
$160.33 - $189.41 $167,063 - $197,365
1,042 Added 4.54%
24,005 $4.31 Million
Q1 2018

Apr 30, 2018

BUY
$161.53 - $178.11 $115,332 - $127,170
714 Added 3.21%
22,963 $3.71 Million
Q4 2017

Feb 08, 2018

BUY
$147.99 - $163.95 $3.29 Million - $3.64 Million
22,210 Added 56948.72%
22,249 $3.55 Million
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $5,829 - $6,261
39
39 $6,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.